Paperonium

← Back to the plain-language case

Table 3's Z statistics imply p-values of 0.16 to 0.60, not 0.001 to 0.15

PLoS Med (2026) Β· doi:10.1371/journal.pmed.1005132 Β· PMC13313369

Summary

Table 3 reports Wilcoxon Z statistics and p-values for three patient-journey intervals of a pre-post training programme, and the Results repeat the p-values as evidence that patient delay (p = 0.02) and diagnostic delay (p < 0.001) fell. Under the stated Wilcoxon test, whose Z has a standard-normal reference, the printed Z values (0.53, 1.41, βˆ’0.55) give two-sided p-values of 0.60, 0.16 and 0.58, while the printed p-values (0.02, 0.001, 0.15) would need |Z| of about 2.33, 3.29 and 1.44. The other 11 Z/p pairs in the paper's S1 Table follow the normal relation, so only these three rows are inconsistent, and no rounding, one-sided, exact or adjusted test reconciles them. If the Z values are correct, neither the headline 54% drop in diagnostic delay nor the 9% drop in patient delay is statistically significant, which removes the stated statistical support for the abstract's "reduced diagnostic delays"; the published information does not show which column is wrong.

What the paper reports

All quotations were checked verbatim against the PMC-archived text with src/show.py. The table rows were also checked against the publisher's XML and PDF (see Status).

Table 3, "Main indicators change of intervention" (columns: interval; pre-intervention median (IQR); post-intervention median (IQR); % change; Z; P-value):

Symptom onset β†’ first medical contact (Patient Delay) | 27 (IQR = 49) | 24.5 (IQR = 44.5) | -9.3% | 0.53 | 0.02

Symptom onset β†’ diagnosis at first medical contact (Diagnostic Delay) | 56.5 (IQR = 87.5) | 25.8 (IQR = 40.3) | -54.2% | 1.41 | 0.001

Diagnosis at oncology center β†’ treatment initiation (Treatment Delay)a | 69 (IQR = 91.5) | 15.9 (IQR = 21.1) | -76.9%a | -0.55 | 0.15

The only footnote (a) concerns the definition of treatment delay.

Methods, Analysis:

Stata 17 was used for quantitative data analysis. Descriptive statistics (medians, interquartile ranges) characterized delays and KAP distributions. The Wilcoxon signed-rank test compared pre- and post-training KAP scores and interval changes.

Methods, Study of the intervention:

Patient-journey intervals (symptom onset to first contact; first contact to confirmed diagnosis; diagnosis to treatment) were extracted from 100 pediatric oncology charts at baseline and 6 months post-implementation, which are all available charts during the study period.

Results, Process measures and outcomes:

Six months post-intervention, patient delay decreased by 9.3% (to 24.5 days, p = 0.02), the diagnostic interval decreased by 54.3% (to 25.8 days, p < 0.001), and the interval from diagnosis to treatment initiation increased by 11.9% (to 15.9 days, p = 0.15). Treatment initiation at the oncology center accelerated from a median of 69.0 to 15.9 days (-76.9%) (Tables 3 and S1).

Abstract, Methods and findings:

and the time from first contact to confirmed diagnosis decreased by 54.2%. Treatment initiation interval increased by 11.9%, reflecting ongoing infrastructural constraints.

Abstract, Conclusions:

A context-tailored, multilevel training and mentorship model was associated with improved provider capacity and reduced diagnostic delays in Northwest Ethiopia.

Author summary:

The median interval from symptom onset to diagnosis decreased by 54.2%, and patient delay decreased by 10.3%.

Discussion:

Compared with similar efforts in Tanzania and Uganda, which achieved 30%–40% reductions in diagnostic delays through clinician workshops alone, our 54% decrease likely reflects the added impact of engaging community health workers and formalizing referral protocols [16,23–25].

The intervention’s success is driven by concurrent gains in provider capacity, shortened diagnostic timelines, and strengthened interdisciplinary collaboration, which collectively demonstrate the model’s operational viability.

S1 Table (supporting file .s005, "Mean difference between stages of cancer and types of interventions"), column headed "Wilcoxon ranked-sum test Groups of intervention (pre & post)", gives the same three pairs (Patient delay 0.53 / 0.02; Diagnostic Delay 1.41 / 0.001; Treatment Delay βˆ’0.55 / 0.15) and 11 further Z / Sig. pairs for other intervals.

What the paper's own numbers show

Method. Stata's signrank and ranksum commands, like the Wilcoxon tests in other packages, report a standardized statistic Z and the two-sided p-value p = 2[1 βˆ’ Ξ¦(|Z|)], where Ξ¦ is the standard normal distribution function. I applied this relation to each printed Z, and inverted it to find the |Z| each printed p requires. To test robustness, I allowed for rounding of Z (Β±0.005) and of p, replaced the normal reference with t distributions (df 5 to 99), computed exact (permutation) Wilcoxon p-values for signed-rank samples of 20, 50 and 100 and rank-sum samples of 10 + 10 and 50 + 50, and applied the same relation to the other 11 pairs in S1 Table as a control. Every number below is printed by recompute.py.txt.

Quantity Location Reported Recomputed from the paper's own numbers
Patient delay: p for Z = 0.53 Table 3, row 1; S1 Table; Results 0.02 0.596 two-sided (0.593 to 0.600 over Z rounding); one-sided 0.298
Diagnostic delay: p for Z = 1.41 Table 3, row 2; S1 Table; Results ("p < 0.001") 0.001 0.159 two-sided (0.157 to 0.160); one-sided 0.079
Treatment delay: p for Z = βˆ’0.55 Table 3, row 3; S1 Table; Results 0.15 0.582 two-sided (0.579 to 0.586); one-sided 0.291
|Z| needed for the printed p β€” 0.02; 0.001; 0.15 2.33 (2.24 to 2.43 over rounding of p); 3.29 (3.17 to 3.48; "p < 0.001" needs > 3.29); 1.44 (1.42 to 1.46)
Ratio, recomputed / printed p β€” β€” 29.8; 158.5; 3.9
p with a t reference, df = 5, 30, 99 β€” β€” 0.619, 0.600, 0.597; 0.218, 0.169, 0.162; 0.606, 0.586, 0.584
Exact Wilcoxon p, signed-rank n = 20, 50, 100 β€” β€” 0.596, 0.598, 0.597; 0.165, 0.160, 0.159; 0.596, 0.585, 0.585
Exact Wilcoxon p, rank-sum 10 + 10 and 50 + 50 β€” β€” 0.579, 0.599; 0.165, 0.159; 0.579, 0.585
Bonferroni over the three rows β€” β€” 1.0; 0.476; 1.0
Other 11 Z / Sig. pairs in S1 Table S1 Table e.g. 1.24 / 0.22; 2.64 / 0.01; βˆ’0.77 / 0.44; βˆ’0.98 / 0.33; βˆ’0.40 / 0.69; βˆ’0.13 / 0.90; five with |Z| 6.47 to 12.10 / < 0.001 0.215; 0.008; 0.441; 0.327; 0.689; 0.897; all < 10βˆ’10: all 11 consistent
Patient delay % change, 27 β†’ 24.5 Table 3; Results; Author summary and Discussion βˆ’9.3%; "10.3%" βˆ’9.26%
Diagnostic delay % change, 56.5 β†’ 25.8 Table 3; Results βˆ’54.2%; "54.3%" βˆ’54.34%
Treatment delay % change, 69 β†’ 15.9 Table 3; Results; Abstract βˆ’76.9%; "increased by 11.9%" βˆ’76.96%

The medians and percentage changes in Table 3 reproduce to rounding (with a 0.1-point discrepancy between βˆ’54.2% in the table and 54.3% in the text). The inferential columns do not: all three Z/p pairs fall far off the normal relation that the paper's other 11 Wilcoxon pairs follow. For the diagnostic-delay row the printed p is 159 times smaller than the p implied by its Z. The paper gives no patient-level interval data (S4 File holds only clinician knowledge, attitude and practice scores), so the Wilcoxon tests cannot be re-run, and the correct Z or p cannot be recovered.

Figure

Each printed p-value in Table 3 is far smaller than the p-value its own Z statistic gives

Figure 1. For each Table 3 row, the p-value printed in the table (orange diamonds) and the p-value implied by the printed Z under the stated Wilcoxon test with its standard-normal reference (blue: filled circle two-sided, open circle one-sided), on one log-scale axis. The thin dashed line marks p = 0.05. The printed values are 0.02, 0.001 and 0.15; the two-sided values implied by Z = 0.53, 1.41 and βˆ’0.55 are 0.60, 0.16 and 0.58, and the one-sided values 0.30, 0.08 and 0.29. Rounding of Z to two decimals moves the two-sided values by at most 0.004, less than a marker width. Patient delay and diagnostic delay lie on opposite sides of the 0.05 line depending on which column is believed.

The other Z/p pairs in S1 Table lie on the normal curve; the three Table 3 pairs do not

Figure 2. All Wilcoxon Z / p pairs printed in the paper's S1 Table, plotted against the relation p = 2[1 βˆ’ Ξ¦(|Z|)] (blue curve); p on a log scale. Open orange circles are the six printed pairs with |Z| below 3.6 outside Table 3; each lies on the curve to within rounding. Five further pairs with |Z| from 6.47 to 12.10 are printed as p < 0.001, also consistent, and are not drawn. The three Table 3 pairs (orange diamonds, with the p their Z implies in blue) are the only ones off the curve, by factors of 3.9 to 159. The thin dashed line marks p = 0.05.

Why it matters

Explanations considered

Status

Suggested correction

The authors may wish to re-run the interval comparisons in Table 3 and S1 Table and report, for each row, the test actually used (signed-rank for paired data, or rank-sum if baseline and follow-up charts are from different patients, with the Methods amended to match), the Z statistic and the p-value that the software gives for it. If the printed Z values are correct, Table 3 would read approximately: patient delay Z = 0.53, p = 0.60; diagnostic delay Z = 1.41, p = 0.16; treatment delay Z = βˆ’0.55, p = 0.58. The Results sentence would then need its p-values changed, and the Abstract conclusion, Author summary, Discussion and concluding paragraph would need to describe the reductions in patient and diagnostic delay as not statistically significant. If instead the p-values are correct, the Z column should be corrected so that each Z matches its p. In either case, the authors may also wish to reconcile the treatment-delay direction ("increased by 11.9%" in the Abstract and Results against βˆ’76.9% in Table 3) and the patient-delay figure (10.3% in the Author summary and Discussion against 9.3% elsewhere), and to report the number of charts in each period.